Mice were sacrificed at the planned endpoint (day 19) of the experiment, when the average tumor volume in the treatment group remained significantly smaller (−30 %) compared to the control (p = 0.005, MALAT1-ASO: 145 mm3, SD = 28 mm3 vs. Control-ASO: 208 mm3, SD = 7 mm3). The gene discussed is MALAT1; the disease is neoplasm.